Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
108,482,196
-
Share change
-
-9,209,105
-
Total reported value
-
$620,176,626
-
Put/Call ratio
-
29%
-
Price per share
-
$5.72
-
Number of holders
-
172
-
Value change
-
-$95,377,953
-
Number of buys
-
88
-
Number of sells
-
76
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2022
As of 31 Mar 2022,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,482,196 shares.
The largest 10 holders included
STATE STREET CORP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, TANG CAPITAL MANAGEMENT LLC, PFM Health Sciences, LP, and PALISADE CAPITAL MANAGEMENT LLC/NJ.
This page lists
172
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.